melatonin has been researched along with Arteriosclerosis, Coronary in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to assess the effects of 5 mg melatonin before sleep in patients with coronary artery disease (CAD) and with an abnormal circadian pattern of blood pressure (BP) on changes in circadian BP profile and heart rate variability (HRV)." | 9.14 | Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability. ( Krzemińska-Pakuła, M; Kurpesa, M; Rechciński, T; Trzos, E; Wierzbowska-Drabik, K, 2010) |
| "Twenty-four hour noninvasive blood pressure monitoring performed before and during melatonin cure is crucial by considering benefits and dangers of this treatment begun in purpose to modify impaired pattern of blood pressure in patients with coronary artery disease." | 9.12 | [The influence of melatonin supplementation on circadian pattern of blood pressure in patients with coronary artery disease--preliminary report]. ( Krzeminska-Pakuła, M; Kurpesa, M; Rechciński, T; Trzos, E, 2006) |
| " Sleep, circadian rhythm characteristics, and melatonin levels in later life adults with and without coronary artery disease." | 8.31 | Sleep, circadian rhythm characteristics, and melatonin levels in later life adults with and without coronary artery disease. ( Albashayreh, A; Benson, CJ; Burgess, HJ; Moon, C; Perkhounkova, Y, 2023) |
| "Decreased night-time plasma levels of melatonin were recently reported in patients with coronary artery disease, and it was postulated that melatonin production may be impaired, due to a lack of synthesizing enzymes." | 7.70 | Decreased melatonin synthesis in patients with coronary artery disease. ( Eber, B; Klein, W; Lercher, P; Liebmann, PM; Sakotnik, A; Schauenstein, K; Stoschitzky, K, 1999) |
| "Melatonin has cardioprotective properties via its direct free radical scavenging and its indirect antioxidant activity." | 6.48 | The role of melatonin in acute myocardial infarction. ( Abreu-Gonzalez, P; Avanzas, P; Dominguez-Rodriguez, A, 2012) |
| "We hypothesised that melatonin may represent a safe somniferous drug for cardiac patients, and assessed the effects of administering 5 mg of melatonin daily before bedtime for 30 days in patients with coronary artery disease (CAD) regarding changes in the nocturnal breathing pattern." | 5.16 | Melatonin - a somniferous option which does not aggravate sleep-disordered breathing in cardiac risk patients: a Holter ECG based study. ( Kasprzak, JD; Krzemińska-Pakuła, M; Kurpesa, M; Rechciński, T; Trzos, E; Uznańska-Loch, B; Wierzbowska-Drabik, K, 2012) |
| "The aim of this study was to assess the effects of 5 mg melatonin before sleep in patients with coronary artery disease (CAD) and with an abnormal circadian pattern of blood pressure (BP) on changes in circadian BP profile and heart rate variability (HRV)." | 5.14 | Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability. ( Krzemińska-Pakuła, M; Kurpesa, M; Rechciński, T; Trzos, E; Wierzbowska-Drabik, K, 2010) |
| "Twenty-four hour noninvasive blood pressure monitoring performed before and during melatonin cure is crucial by considering benefits and dangers of this treatment begun in purpose to modify impaired pattern of blood pressure in patients with coronary artery disease." | 5.12 | [The influence of melatonin supplementation on circadian pattern of blood pressure in patients with coronary artery disease--preliminary report]. ( Krzeminska-Pakuła, M; Kurpesa, M; Rechciński, T; Trzos, E, 2006) |
| " Sleep, circadian rhythm characteristics, and melatonin levels in later life adults with and without coronary artery disease." | 4.31 | Sleep, circadian rhythm characteristics, and melatonin levels in later life adults with and without coronary artery disease. ( Albashayreh, A; Benson, CJ; Burgess, HJ; Moon, C; Perkhounkova, Y, 2023) |
| " Myocyte necrosis and fibrosis were diminished with melatonin while vasculitis was prevented." | 3.80 | Histopathological evaluation of melatonin as a protective agent in heart injury induced by radiation in a rat model. ( Erkal, HŞ; Gürses, I; Özeren, M; Serin, M; Yücel, N, 2014) |
| "Decreased night-time plasma levels of melatonin were recently reported in patients with coronary artery disease, and it was postulated that melatonin production may be impaired, due to a lack of synthesizing enzymes." | 3.70 | Decreased melatonin synthesis in patients with coronary artery disease. ( Eber, B; Klein, W; Lercher, P; Liebmann, PM; Sakotnik, A; Schauenstein, K; Stoschitzky, K, 1999) |
| "Melatonin has cardioprotective properties via its direct free radical scavenging and its indirect antioxidant activity." | 2.48 | The role of melatonin in acute myocardial infarction. ( Abreu-Gonzalez, P; Avanzas, P; Dominguez-Rodriguez, A, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moon, C | 1 |
| Benson, CJ | 1 |
| Albashayreh, A | 1 |
| Perkhounkova, Y | 1 |
| Burgess, HJ | 1 |
| Gürses, I | 1 |
| Özeren, M | 1 |
| Serin, M | 1 |
| Yücel, N | 1 |
| Erkal, HŞ | 1 |
| Dominguez-Rodriguez, A | 2 |
| Abreu-Gonzalez, P | 2 |
| Reiter, RJ | 1 |
| Rechciński, T | 3 |
| Trzos, E | 3 |
| Wierzbowska-Drabik, K | 2 |
| Krzemińska-Pakuła, M | 3 |
| Kurpesa, M | 3 |
| Uznańska-Loch, B | 1 |
| Kasprzak, JD | 1 |
| Szymański, FM | 1 |
| Avanzas, P | 1 |
| Domínguez Rodríguez, A | 1 |
| García González, MJ | 1 |
| Abreu González, P | 1 |
| Ferrer Hita, J | 1 |
| Sakotnik, A | 1 |
| Liebmann, PM | 1 |
| Stoschitzky, K | 1 |
| Lercher, P | 1 |
| Schauenstein, K | 1 |
| Klein, W | 1 |
| Eber, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Triple Blinded Randomized Controlled Trial of Oral Melatonin in Elevated Blood Pressure Individual (MRCTEBP)[NCT03764020] | Phase 3 | 320 participants (Anticipated) | Interventional | 2019-06-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for melatonin and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Clinical aspects of melatonin in the acute coronary syndrome.
Topics: Acute Coronary Syndrome; Animals; Cardiovascular System; Coronary Artery Disease; Humans; Melatonin; | 2009 |
The role of melatonin in acute myocardial infarction.
Topics: Animals; Cardiotonic Agents; Circadian Rhythm; Coronary Artery Disease; Humans; Melatonin; Models, C | 2012 |
3 trials available for melatonin and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Coronary Angiogr | 2010 |
Melatonin - a somniferous option which does not aggravate sleep-disordered breathing in cardiac risk patients: a Holter ECG based study.
Topics: Aged; Aged, 80 and over; Central Nervous System Depressants; Circadian Rhythm; Coronary Artery Disea | 2012 |
[The influence of melatonin supplementation on circadian pattern of blood pressure in patients with coronary artery disease--preliminary report].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Monitoring, | 2006 |
5 other studies available for melatonin and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Sleep, circadian rhythm characteristics, and melatonin levels in later life adults with and without coronary artery disease.
Topics: Adult; Aged; Circadian Rhythm; Coronary Artery Disease; Cross-Sectional Studies; Female; Humans; Mel | 2023 |
Histopathological evaluation of melatonin as a protective agent in heart injury induced by radiation in a rat model.
Topics: Animals; Cardiomyopathies; Coronary Artery Disease; Coronary Vessels; Cytoprotection; Fibrosis; Male | 2014 |
[Comment to article Pacjent z OSA - o czym warto pamiętać?].
Topics: Central Nervous System Depressants; Coronary Artery Disease; Female; Humans; Male; Melatonin; Sleep | 2012 |
[Circadian rhythm in acute coronary syndrome].
Topics: Acute Disease; Circadian Rhythm; Coronary Artery Disease; Humans; Melatonin; Periodicity; Pineal Gla | 2005 |
Decreased melatonin synthesis in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Case-Control Studies; Circadian Rhyt | 1999 |